Flagship Pioneering Special Opportunities Fund Ii General Partner Llc - Net Worth and Insider Trading
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc Net Worth
The estimated net worth of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc is at least $34 Million dollars as of 2024-11-05. Flagship Pioneering Special Opportunities Fund Ii General Partner Llc is the 10% Owner of Omega Therapeutics Inc and owns about 29,225,579 shares of Omega Therapeutics Inc (OMGA) stock worth over $34 Million. Details can be seen in Flagship Pioneering Special Opportunities Fund Ii General Partner Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Flagship Pioneering Special Opportunities Fund Ii General Partner Llc has not made any transactions after 2023-02-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Pioneering Special Opportunities Fund Ii General Partner Llc owns 3 companies in total, including Foghorn Therapeutics Inc (FHTX) , Sigilon Therapeutics Inc (SGTX) , and Omega Therapeutics Inc (OMGA) .
Insider Ownership Summary of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2020-10-22 | 10 percent owner |
| SGTX | Sigilon Therapeutics Inc | 2020-12-03 | 10 percent owner |
| OMGA | Omega Therapeutics Inc | 2023-02-27 | 10 percent owner |
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc Latest Holdings Summary
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc currently owns a total of 1 stock. Flagship Pioneering Special Opportunities Fund Ii General Partner Llc owns 29,225,579 shares of Omega Therapeutics Inc (OMGA) as of February 27, 2023, with a value of $34 Million.
Latest Holdings of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OMGA | Omega Therapeutics Inc | 2023-02-27 | 29,225,579 | 1.16 | 33,901,672 |
Holding Weightings of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Flagship Pioneering Special Opportunities Fund Ii General Partner Llc has made a total of 1 transactions in Omega Therapeutics Inc (OMGA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Omega Therapeutics Inc is the acquisition of 3,323,310 shares on February 27, 2023, which cost Flagship Pioneering Special Opportunities Fund Ii General Partner Llc around $19 Million.
Insider Trading History of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc
- 1
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc Trading Performance
GuruFocus tracks the stock performance after each of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Flagship Pioneering Special Opportunities Fund Ii General Partner Llc is 33.79%. GuruFocus also compares Flagship Pioneering Special Opportunities Fund Ii General Partner Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Flagship Pioneering Special Opportunities Fund Ii General Partner Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Flagship Pioneering Special Opportunities Fund Ii General Partner Llc's insider trading performs compared to the benchmark.
Performance of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.64 | | | | | |
| Relative Return to S&P 500(%) | 16.76 | | | | | |
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc Ownership Network
Ownership Network List of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc
Ownership Network Relation of Flagship Pioneering Special Opportunities Fund Ii General Partner Llc
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Flagship Pioneering Special Opportunities Fund Ii General Partner Llc made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 58,859 shares made by Carlos Costa , a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 20,000 shares made by Steven F. Bellon .
In summary, during the past 3 months, insiders sold 78,859 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 78,859 shares. During the past 18 months, 401,156 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 401,156 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Flagship Pioneering Special Opportunities Fund Ii General Partner Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Pioneering Special Opportunities Fund Ii General Partner Llc. You might contact Flagship Pioneering Special Opportunities Fund Ii General Partner Llc via mailing address: 55 Cambridge Parkway, 8th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
